The impact of using probiotics on metabolic disorders of women with polycystic ovary syndrome
DOI:
https://doi.org/10.12775/QS.2023.09.02.002Keywords
polycystic ovary syndrome, PCOS, probiotics, gut microbiota, gut microbiomeAbstract
Introduction: Polycystic ovary syndrome is a common endocrine and metabolic disorder affecting women of reproductive age. The course is primarily associated with menstrual disorders, obesity, insulin resistance and hyperandrogenism. The gut microbiota dysbiosis theory (DOGMA), established in 2012, suggests a link between the composition of gut bacteria and the development of metabolic disorders. Other studies confirm this relationship. This article analyzes the effect of probiotic supplementation on the alteration of gut microbial flora and the course of PCOS.
Aim of the study: Aim of our study was to review the available studies on the effect of probiotic use on the course of polycystic ovary syndrome. We considered the influence of supplementation on body weight, insulin resistance and lipid profile of the women studied.
Methods and materials: This article is based on the literature found in PubMed Database with use of keywords such as “PCOS”; „polycystic ovary syndrome”; “probiotics”; „gut microbiota”; „gut microbiome”.
Results: The collective results of the reviewed literature indicate that probiotics may have a beneficial effect on the course of polycystic ovary syndrome. In a number of studies, their supplementation resulted in a decrease in weight, insulin, triglycerides and VLDL cholesterol. For fasting glucose, HOMAR-IR, total cholesterol and LDL fraction, the results were inconclusive.
Conclusion: Probiotics may have a positive effect on metabolic disorders in women with PCOS, but more research is needed to confirm the good effects of their use in treatment.
References
Tan S., Scherag A., Janssen, et al. (2010). Large effects on body mass index and insulin resistance of fat mass and obesity asso- ciated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS). BMC Medical Genetics, 11, 12. doi:10.1186/1471-2350-11-12.
Conway G., Dewailly D., Diamanti-Kandarakis E., et al. (2014). The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur. J. Endocrinol. 171, 1–29. doi: 10.1530/EJE-14-0253
Li Y.; Chen C.; Ma Y.; et al. Multi-system reproductive metabolic disorder: Significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS). Life Sci. 2019, 228, 167–175.
Franks S.; I McCarthy M.; Hardy K. Development of polycystic ovary syndrome: Involvement of genetic and environmental factors. Int. J. Androl. 2006, 29, 278–285.
Cani P.D.; Amar J.; Iglesias M.A.; et al. Metabolic Endotoxemia Initiates Obesity and Insulin Resistance. Diabetes 2007, 56, 1761–1772.
Turnbaugh P.J.; Ley R.E.; Mahowald M.A.; et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nat. Cell Biol. 2006, 444, 1027–1031.
Tremellen K, Pearce K. Dysbiosis of gut microbiota (DOGMA)–a novel theory for the development of polycystic ovarian syn- drome. Med Hypotheses. 2012;79(1):104–112.
Hong X.; Qin P.; Huang K.; et al. Association between polycystic ovary syndrome and the vaginal microbiome: A case-control study. Clin. Endocrinol. 2020, 93, 52–60.
Pickard JM, Chervonsky AV. Intestinal fucose as a mediator of host-mi- crobe symbiosis. J Immunol 2015; 194: 5588–5593
Macfarlane GT, Macfarlane S. Human colonic microbiota: ecology, physiology and metabolic potential of intestinal bacteria. Scand J Gastroenterol Suppl. 1997; 222: 3–9
Consortium HMP. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486: 207–214
FAO/WHO (2001) Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria.
Ahmadi, S.; Jamilian, M.; Karamali, M.; et al. Probiotic supplementation and the effects on weight loss, glycaemia and lipid profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. Hum. Fertil. 2017, 20, 254–261.
Giampaolino P.; Foreste V.; Di Filippo, et al. Microbiome and PCOS: State-of-Art and Future Aspects. Int. J. Mol. Sci. 2021, 22, 2048. https://doi.org/ 10.3390/ijms22042048
Gomes A.C., de Sousa R.G.M., Botelho P.B., et al. The additional effects of a probiotic mix on abdominal adiposity and antioxidant Status: A double-blind, randomized trial. Obesity. 2017;25:30–38.
Kim J., Yun J.M., Kim M.K., et al. Lactobacillus gasseri BNR17 Supplementation Reduces the Visceral Fat Accumulation and Waist Circumference in Obese Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. J. Med. Food. 2018;21:454–461.
Sanchez M., Darimont C., Drapeau V., et al. Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. British Journal of Nutrition, 2014; 111, 1507–1519.
Zhang F, Ma T, Cui P, et al. (2019) Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine. Front. Microbiol. 10:175. doi: 10.3389/fmicb.2019.00175
da Silva Rosa S.C., Nayak N., Caymo A.M., Gordon J.W.: Mechanisms of muscle insulin resistance and the cross-talk with liver and adipose tissue. Physiol. Rep., 2020; 8: e14 607
Chae S.J., Kim J.J., Choi Y.M. et al.: Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women. Human Reproduction, 2008; 23: 1924–1931
Bäckhed, F.; Ding, H.; Wang, T.; et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA 2004, 101, 15718–15723.
Scheithauer, T.P.M.; Dallinga-Thie, et al. Causality of small and large intestinal microbiota in weight regulation and insulin resistance. Mol. Metab. 2016, 5, 759–770.
Shoaei, T., Heidari-Beni, M., Tehrani, et al. Effects of probiotic supplementation on pancreatic beta-cell function and C- reactive protein in women with polycystic ovary syn- drome: A randomized double-blind placebo-controlled clinical trial. International Journal of Preventative Medicine, 2015; 6, 27.
Valkenburg O, Steegers-Theunissen RPM, Smedts HPM, et al. A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study. J Clin Endocrinol Metab. 2008; 93(2): 470–476, doi: 10.1210/jc.2007-1756, indexed in Pubmed: 18056772.
Rajkumar, H., Kumar, M., Das, N., et al. (2015). Effect of probiotic Lactobacillus salivarius UBL S22 and prebiotic fructo-oligosaccharide on serum lipids, inflammatory markers, insulin sensitivity, and gut bacteria in healthy young volunteers: A randomized con- trolled single-blind pilot study. Journal of Cardiovascular Pharmacology and Therapeutics, 20, 289–298.
Akkasheh, G., Kashani-Poor, Z., Tajabadi-Ebrahimi, M., et al. (2015). Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial. Nutrition, 32, 315–320. doi:10.1016/j.nut.2015.09.003.
Asemi, Z., Samimi, M., Tabasi, Z., et al. (2012). Effect of daily consumption of probiotic yoghurt on lipid profiles in pregnant women: a randomized controlled clinical trial. Journal of Maternal-Fetal and Neonatal Medicine, 25, 1552–1556. doi:10.3109/14767058.2011.640372.
Samimi M., Dadkhah A., Kashani H.H., et al. The effects of synbiotic supplementation on metabolic status in women with polycystic ovary syndrome: A randomized double-blind clinical trial. Probiotics Antimicrob. Proteins. 2019;11:1355–1361. doi: 10.1007/s12602-018-9405-z.
Liao D, Zhong C, Li C, et al. Meta-analysis of the effects of probiotic supplementation on glycemia, lipidic profiles, weight loss and C-reactive protein in women with polycystic ovarian syndrome. Minerva Med. 2018;109(6):479–87.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Zuzanna Wesołowska, Sylwia Zdun, Klaudia Walczak, Weronika Gaweł, Przemysław Jędruszczak
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 1058
Number of citations: 0
